In vitro studies of antiglaucomatous prostaglandin analogues: travoprost with and without benzalkonium chloride and preserved latanoprost.
暂无分享,去创建一个
[1] G. Gedıkoğlu,et al. Effects of antiglaucoma drugs on ocular surface. , 2009, Acta ophthalmologica Scandinavica.
[2] C. Baudouin. Allergic reaction to topical eyedrops. , 2005, Current opinion in allergy and clinical immunology.
[3] C. Baudouin,et al. In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells. , 2005, Investigative ophthalmology & visual science.
[4] David A. Lee,et al. Glaucoma and its treatment: a review. , 2005, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[5] C. Creuzot-Garcher,et al. Conjunctival epithelial cell expression of interleukins and inflammatory markers in glaucoma patients treated over the long term. , 2004, Ophthalmology.
[6] C. Creuzot-Garcher,et al. Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study. , 2004, Investigative ophthalmology & visual science.
[7] W. Petroll,et al. Evaluation of the Corneal Effects of Topical Ophthalmic Fluoroquinolones Using In Vivo Confocal Microscopy , 2004, Eye & contact lens.
[8] S. Kinoshita,et al. Comparison of the Short-Term Effects on the Human Corneal Surface of Topical Timolol Maleate With and Without Benzalkonium Chloride , 2003, Journal of glaucoma.
[9] W. C. Stewart,et al. Intraocular Pressure, Safety and Quality of Life in Glaucoma Patients Switching to Latanoprost from Adjunctive and Monotherapy Treatments , 2003, European journal of ophthalmology.
[10] C. Camras. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. , 2002, American journal of ophthalmology.
[11] G. Feldmann,et al. Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells. , 1999, Investigative ophthalmology & visual science.
[12] A. Béchetoille,et al. Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies. , 1999, Ophthalmology.
[13] C. Baudouin,et al. Expression of Fas-Fas ligand antigens and apoptotic marker APO2.7 by the human conjunctival epithelium. Positive correlation with class II HLA DR expression in inflammatory ocular surface disorders. , 1998, Experimental eye research.
[14] C. Baudouin,et al. Short term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteers , 1998, The British journal of ophthalmology.
[15] D. Doughman,et al. A new, simple, nonradioactive, nontoxic in vitro assay to monitor corneal endothelial cell viability. , 1997, Investigative ophthalmology & visual science.
[16] J. V. van Best,et al. Effect of timolol with and without preservative on the basal tear turnover in glaucoma. , 1995, The British journal of ophthalmology.
[17] C. O'brien,et al. Adverse effects of topical antiglaucoma medication. I. The conjunctival cell profile. , 1994 .
[18] C. O'brien,et al. Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery. , 1994 .
[19] P. Gastaud,et al. Expression of inflammatory membrane markers by conjunctival cells in chronically treated patients with glaucoma. , 1994, Ophthalmology.
[20] J. Jester,et al. Confocal Microscopic Studies of Living Rabbit Cornea Treated with Benzalkonium Chloride , 1992, Cornea.
[21] J. Samples,et al. The effect of epinephrine and benzalkonium chloride on cultured corneal endothelial and trabecular meshwork cells. , 1989, Experimental eye research.
[22] R. Hitchings,et al. Long-term morphologic effects of antiglaucoma drugs on the conjunctiva and Tenon's capsule in glaucomatous patients. , 1989, Ophthalmology.
[23] Fisher Aa. Allergic contact dermatitis and conjunctivitis from benzalkonium chloride. , 1987 .
[24] C. Baudouin,et al. Toxicity of preserved and unpreserved antiglaucoma topical drugs in an in vitro model of conjunctival cells. , 1999, Current Eye Research.
[25] P. Gastaud,et al. Histopathological effects of topical ophthalmic preservatives on rat corneoconjunctival surface. , 1998, Current eye research.
[26] T. Idziorek,et al. YOPRO-1 permits cytofluorometric analysis of programmed cell death (apoptosis) without interfering with cell viability. , 1995, Journal of immunological methods.
[27] A. Fisher. Allergic contact dermatitis and conjunctivitis from benzalkonium chloride. , 1987, Cutis.